<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04782284</url>
  </required_header>
  <id_info>
    <org_study_id>MSA-swrehab-RCT</org_study_id>
    <nct_id>NCT04782284</nct_id>
  </id_info>
  <brief_title>Comprehensive Swallowing Rehabilitation in Patients With MSA</brief_title>
  <official_title>Effect of Comprehensive Swallowing Rehabilitation in Patients With Multiple System Atrophy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of comprehensive swallowing&#xD;
      rehabilitation in patients with multiple system atrophy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease&#xD;
      characterized by parkinsonism, cerebellar syndrome, and autonomic failure. Dysphagia is a&#xD;
      clinically significant symptom leading to pneumonia that causes death in patients with MSA.&#xD;
      Although the symptoms of dysphagia in the two subtypes of MSA-the parkinsonian variant and&#xD;
      the cerebellar variant- are different, there is no significant difference in the latency to&#xD;
      onset of tube feeding. Therefore, effective intervention is needed to improve the safety and&#xD;
      efficiency of swallowing regardless of the subtypes of MSA.&#xD;
&#xD;
      Although swallowing rehabilitation has been widely applied for swallowing disorders in&#xD;
      patients with MSA, few studies have reported the clinical effect of applying swallowing&#xD;
      therapy. Comprehensive swallowing rehabilitation has focused on functional muscle training,&#xD;
      compensatory swallowing maneuvers, and thermal-tactile stimulation, which is used to treat&#xD;
      dysphagia from stroke, Parkinson's disease, and head and neck cancer. Therefore, this study&#xD;
      aims to investigate the effect of comprehensive swallowing rehabilitation in patients with&#xD;
      MSA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Penetration-Aspiration Scale</measure>
    <time_frame>at 6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Videofluoroscopic dysphagia scale</measure>
    <time_frame>at 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Penetration-Aspiration Scale</measure>
    <time_frame>at 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Videofluoroscopic dysphagia scale</measure>
    <time_frame>at 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Cough Flow</measure>
    <time_frame>at 6 weeks, at 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Inspiratory Pressure</measure>
    <time_frame>at 6 weeks, at 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Expiratory Pressure</measure>
    <time_frame>at 6 weeks, at 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced vital capacity</measure>
    <time_frame>at 6 weeks, at 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced expiratory volume</measure>
    <time_frame>at 6 weeks, at 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal phonation time</measure>
    <time_frame>at 6 weeks, at 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing disturbance questionnaire</measure>
    <time_frame>at 6 weeks, at 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing Quality of Life questionnaire</measure>
    <time_frame>at 6 weeks, at 12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Multiple System Atrophy</condition>
  <arm_group>
    <arm_group_label>Comprehensive swallowing rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Swallowing education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Comprehensive swallowing rehabilitation</intervention_name>
    <description>The treatment time per session is 30 minutes. Total 12 sessions are provided for 6 weeks.</description>
    <arm_group_label>Comprehensive swallowing rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Swallowing education</intervention_name>
    <description>The education is 30 minutes. Total 1 session is provided immediately after baseline evaluation.</description>
    <arm_group_label>Swallowing education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;19 years&#xD;
&#xD;
          -  Clinically diagnosed with MSA according to the guidelines of the 2nd consensus of the&#xD;
             Gilman criteria&#xD;
&#xD;
          -  Clinically diagnosed to have dysphagia by a physiatrist&#xD;
&#xD;
          -  Two or more points on the Penetration-aspiration scale (PAS) from the&#xD;
             Videofluoroscopic swallowing study (VFSS) conducted within 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Moderate to severe cognitive dysfunction with Mini-mental State Examination score &lt; 19&#xD;
&#xD;
          -  Comorbidities or structural abnormalities that may affect swallowing function&#xD;
&#xD;
          -  Other comorbidities that make it difficult to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Han Gil Seo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Han Gil Seo, MD, PhD</last_name>
    <phone>82-2-2072-1659</phone>
    <email>hgseo80@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Han Gil Seo, MD, PhD</last_name>
      <phone>82-2-2072-1659</phone>
      <email>hgseo80@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 1, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2021</study_first_posted>
  <last_update_submitted>July 1, 2021</last_update_submitted>
  <last_update_submitted_qc>July 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Han Gil Seo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Multiple System Atrophy</keyword>
  <keyword>Dysphagia</keyword>
  <keyword>Swallowing rehabilitation</keyword>
  <keyword>Videofluoroscopic Swallowing Study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple System Atrophy</mesh_term>
    <mesh_term>Shy-Drager Syndrome</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

